Activation of the ErbB3-AKT axis promotes melanoma cell survival and proliferation in response to RAF/MEK inhibition

Benzer Materyaller

• Activation of an early feedback survival loop involving phospho-ErbB3 is a general response of melanoma cells to RAF/MEK inhibition and is abrogated by anti-ErbB3 antibodies
  Yazar:: Fattore, Luigi, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors
  Yazar:: Fattore, Luigi, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Combination of antibodies directed against different ErbB3 surface epitopes prevents the establishment of resistance to BRAF/MEK inhibitors in melanoma
  Yazar:: Fattore, Luigi, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• The promise of anti-ErbB3 monoclonals as new cancer therapeutics
  Yazar:: Aurisicchio, Luigi, ve diğerleri
  Baskı/Yayın Bilgisi: (2012)
• Combination therapy with anti-ErbB3 monoclonal antibodies and EGFR TKIs potently inhibits Non-small Cell Lung Cancer
  Yazar:: Noto, Alessia, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)